Published Date: 02 Mar 2023
Spain: A recent study showed an increase in subclinical autonomic neuropathy (CAN) in women aged 1...
Read Full NewsRoger discusses how new therapies are transforming asthma treatment, enabling potential clinical remission.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on Phosphorylated tau 181!
Here's some of what is coming soon to NeurologyLive® this week.
Baptist Health Brain & Spine enhances its neurology leadership with Peter Abdelmalik, MD, focusing on patient care, education, and operational efficiency.
A Korean study reveals that adjusted MMSE thresholds significantly increase eligibility for anti-amyloid treatments, highlighting demographic disparities and safety concerns.
New findings reveal the feasibility of self-administering remternetug, a monoclonal antibody for Alzheimer’s, enhancing treatment options for early-stage patients.
Rewriting Airway Disease With Trait-Based Care: 2025’s Convergence of Asthma and COPD Management
1.
The top three drugs for multiple myeloma treatment upfront are four.
2.
On all CAR-T products, the FDA is calling for a new boxed warning.
3.
How access to specialized cancer centers affects glioblastoma outcomes
4.
Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.
5.
'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma
1.
Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options
2.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
3.
Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients
4.
Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates
5.
Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
3.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Thromboprophylaxis In Medical Settings
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation